Malignant  	Malignant  	 JJ	B-NP
stroke  	stroke  	 NN	I-NP
in  	in  	 IN	O
an  	an  	 DT	O
adolescent  	adolescent  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
homozygous  	homozygous  	 JJ	O
MTHFR  	MTHFR  	 NNP	O
677CT  	677CT  	 NNP	O
mutation  	mutation  	 NN	O
and  	and  	 CC	O
intake  	intake  	 NN	O
of  	of  	 IN	O
hormonal  	hormonal  	 JJ	B-NP
contraceptives  	contraceptives  	 NNS	I-NP
Severe  	Severe  	 JJ	I-NP
stroke  	stroke  	 NN	I-NP
in  	in  	 IN	O
children  	children  	 NNS	O
and  	and  	 CC	O
adolescents  	adolescents  	 NNS	O
with  	with  	 IN	O
its  	its  	 PRP$	O
devastating  	devastating  	 JJ	O
long  	long  	 JJ	O
term  	term  	 NN	B-NP
consequences  	consequences  	 NNS	I-NP
remains  	remains  	 VBZ	O
a  	a  	 DT	O
rare  	rare  	 JJ	O
disorder  	disorder  	 NN	O
with  	with  	 IN	O
many  	many  	 JJ	O
open  	open  	 JJ	O
questions 	questions 	 NNS	O
.  	.  	 .	O
Beside  	Beside  	 IN	O
the  	the  	 DT	O
well  	well  	 RB	O
known  	known  	 VBN	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
such  	such  	 JJ	O
as  	as  	 IN	O
infection  	infection  	 NN	B-NP
or  	or  	 CC	O
congenital  	congenital  	 NNS	O
and  	and  	 CC	O
acquired  	acquired  	 VBN	B-NP
heart  	heart  	 NN	I-NP
disease 	disease 	 NN	I-NP
,  	,  	 ,	O
coagulation  	coagulation  	 JJ	B-NP
disorders  	disorders  	 NNS	I-NP
have  	have  	 VBP	O
to  	to  	 TO	O
be  	be  	 VB	O
considered  	considered  	 VBN	O
in  	in  	 IN	O
the  	the  	 DT	O
differential  	differential  	 JJ	B-NP
work  	work  	 NN	I-NP
up  	up  	 RP	O
of  	of  	 IN	O
the  	the  	 DT	O
underlying  	underlying  	 JJ	O
aetiology 	aetiology 	 NN	O
.  	.  	 .	O
Here  	Here  	 RB	O
we  	we  	 PRP	O
report  	report  	 VBP	O
the  	the  	 DT	O
case  	case  	 NN	O
of  	of  	 IN	O
an  	an  	 DT	O
adolescent  	adolescent  	 NN	B-NP
with  	with  	 IN	O
a  	a  	 DT	O
homozygote  	homozygote  	 JJ	O
MTHFR  	MTHFR  	 NNP	O
677CT  	677CT  	 NNP	O
mutation  	mutation  	 VBZ	O
suffering  	suffering  	 VBG	O
a  	a  	 DT	O
malignant  	malignant  	 JJ	O
stroke  	stroke  	 NN	O
shortly  	shortly  	 RB	O
after  	after  	 IN	O
the  	the  	 DT	O
start  	start  	 NN	O
of  	of  	 IN	O
oral  	oral  	 JJ	B-NP
contraceptives 	contraceptives 	 NNS	I-NP
.  	.  	 .	O
Since  	Since  	 IN	O
prevention  	prevention  	 NN	O
seems  	seems  	 VBZ	O
easily  	easily  	 RB	O
feasible 	feasible 	 JJ	O
,  	,  	 ,	O
general  	general  	 JJ	O
screening  	screening  	 NN	O
for  	for  	 IN	O
MTHFR  	MTHFR  	 NNP	B-NP
mutations  	mutations  	 NNS	I-NP
might  	might  	 MD	O
be  	be  	 VB	O
worthwhile  	worthwhile  	 JJ	O
in  	in  	 IN	O
women  	women  	 NNS	O
before  	before  	 IN	O
starting  	starting  	 VBG	O
oral  	oral  	 JJ	B-NP
contraceptives 	contraceptives 	 NNS	I-NP
.  	.  	 .	O
